These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25872662)

  • 21. Renal cell carcinoma presenting as nephrotic syndrome complicated by acute renal failure.
    Abouchacra S; Duguid WP; Somerville PJ
    Clin Nephrol; 1993 Jun; 39(6):340-2. PubMed ID: 8334762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Family occurrence of steroid-sensitive idiopathic nephrotic syndrome].
    Tusgaard Petersen B; Frydensbjerg Andersen R; Rittig S
    Ugeskr Laeger; 2012 Nov; 174(46):2868-9. PubMed ID: 23153469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability of remission in minimal lesion nephrotic syndrome after treatment with prednisolone and cyclophosphamide.
    Dundon S; O'Callaghan U; Raftery J
    Int J Pediatr Nephrol; 1980 Mar; 1(1):22-5. PubMed ID: 7343524
    [No Abstract]   [Full Text] [Related]  

  • 24. Epidemiology of primary nephrotic syndrome in Egyptian children.
    Kaddah A; Sabry S; Emil E; El-Refaey M
    J Nephrol; 2012; 25(5):732-7. PubMed ID: 22101675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effectiveness of the treatment of a nephrotic form of glomerulonephritis in children].
    Kanatbaeva AB; Mustafina SM; Shparvasser VV; Ti VD
    Pediatriia; 1991; (7):89-91. PubMed ID: 1754335
    [No Abstract]   [Full Text] [Related]  

  • 26. Cyclophosphamide alone in the treatment of adult patients with minimal change glomerulonephritis.
    Al-Khader AA; Lien JW; Aber GM
    Clin Nephrol; 1979 Jan; 11(1):26-30. PubMed ID: 428152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biloma during steroid therapy for minimal change nephrotic syndrome.
    Ohtake T; Kimura M; Yoshii S; Ikegaya N; Takayanagi S; Hishida A; Kaneko E
    Intern Med; 1993 Jul; 32(7):543-6. PubMed ID: 8286831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic cyclosporine-induced nephrotoxicity in children with steroid-resistant nephrotic syndrome.
    Fujinaga S; Shimizu T
    Pediatr Nephrol; 2013 Oct; 28(10):2065-6. PubMed ID: 23780471
    [No Abstract]   [Full Text] [Related]  

  • 29. A new 'tac' for childhood nephrotic syndrome.
    Becknell B; Greenbaum LA; Smoyer WE
    Kidney Int; 2012 Nov; 82(10):1049-51. PubMed ID: 23128115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Nephrotic syndrome. Official report of the Section of Pediatric Nephrology].
    García García L; Martín Govantes J; Navarro Torres M; Simón González J; Vallo Boada A
    An Esp Pediatr; 1982 Oct; 17(4):354-8. PubMed ID: 7158884
    [No Abstract]   [Full Text] [Related]  

  • 31. Steroid-responsive relapsing nephrotic syndrome associated with early diabetic glomerulopathy in a child.
    Peces R; Riera JR; López Larrea C; Alvarez J
    Nephron; 1987; 46(1):78-82. PubMed ID: 3600916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of the effectiveness of various programs of active therapy of primary glomerulonephritis with nephrotic syndrome in children].
    Sten'shinskaia EV
    Pediatriia; 1991; (7):86-9. PubMed ID: 1754334
    [No Abstract]   [Full Text] [Related]  

  • 33. [Good results of cyclophosphamide in steroid toxicity in the treatment of nephrotic syndrome caused by minimal-lesion glomerulopathy in childhood].
    de Moor R; de Jong M; Monnens L
    Ned Tijdschr Geneeskd; 1992 May; 136(18):876-80. PubMed ID: 1589052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of steroid-sensitive nephrotic syndrome in children with type 1 diabetes.
    Goldman M; Hébert D; Geary DF
    Pediatr Nephrol; 2002 May; 17(5):351-4. PubMed ID: 12042892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimal change (steroid sensitive) nephrotic syndrome in children: new aspects on pathogenesis and treatment.
    Oh J; Kemper MJ
    Minerva Pediatr; 2012 Apr; 64(2):197-204. PubMed ID: 22495193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Observations on the "minimal change" lesion: adult onset patients and results of cyclophosphamide treatment in children.
    Cameron JS; Ogg CS; White RH
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():211-6. PubMed ID: 4536423
    [No Abstract]   [Full Text] [Related]  

  • 37. [Long-term follow-up of the effectiveness of cyclophosphamide in corticodependent and corticoresistant infantile nephrosis. 282 cases treated in an 8-year period].
    Forese S; Tamborino G; Genova R
    Minerva Pediatr; 1977 Mar; 29(8):547-50. PubMed ID: 865435
    [No Abstract]   [Full Text] [Related]  

  • 38. A new approach to de novo minimal change disease in pregnancy.
    Gleeson S; Cardoso F; Lightstone L; Webster P; Munro K; Cairns T
    Nephrology (Carlton); 2021 Aug; 26(8):692-693. PubMed ID: 33728704
    [No Abstract]   [Full Text] [Related]  

  • 39. Steroid-responsive nephrotic syndrome with minimal-change disease and IgA deposits in a HIV-infected patient.
    Boix E; Rivera F; Gil CM; Pérez-Contreras J; Olivares J
    Nephrol Dial Transplant; 2000 Mar; 15(3):412-4. PubMed ID: 10692530
    [No Abstract]   [Full Text] [Related]  

  • 40. Adult minimal-change disease: clinical characteristics, treatment, and outcomes.
    Waldman M; Crew RJ; Valeri A; Busch J; Stokes B; Markowitz G; D'Agati V; Appel G
    Clin J Am Soc Nephrol; 2007 May; 2(3):445-53. PubMed ID: 17699450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.